Z-2084-2026 Class II Ongoing

Recalled by DFI Co., Ltd. — Gimhae

FDA device recall Z-2084-2026 was initiated by DFI Co., Ltd. on April 2, 2026 and is designated Class II. Reason for recall: The devices were distributed without required FDA premarket clearance or approval. The recall status is ongoing. Affected quantity: 7860 units.

Recall Details

Product Type
Devices
Report Date
May 13, 2026
Initiation Date
April 2, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7860 units

Product Description

One Step pH in vitro diagnostic test REF: 31I4P

Reason for Recall

The devices were distributed without required FDA premarket clearance or approval.

Distribution Pattern

Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.

Code Information

UDI: 08806141303060/ Lot: 250305, 250415, 250509, 250625, 250905